Read the latest positive news, breakthroughs, and inspiring stories about novartis, curated daily by BrightWire.
Scientists at Novartis have discovered a drug that cured a deadly parasitic disease in mice with just one dose, potentially transforming treatment for six million people worldwide. The breakthrough could replace weeks of therapy with a single pill.
An experimental pill for multiple sclerosis outperformed an approved drug in two major trials, giving 2,000 patients new hope for fewer relapses. The developer plans to seek global approval for the treatment.
A new multiple sclerosis treatment from Novartis has achieved positive results in clinical trials, offering fresh hope to millions living with this challenging autoimmune disease. The BTK inhibitor represents a promising advance in MS care.
A newly tested Novartis drug successfully reduced inflammation markers that contribute to heart disease, bringing hope for better cardiovascular treatments. Higher doses showed even stronger results, proving the medicine works as designed.
